AngioDynamics Statistics
Total Valuation
AngioDynamics has a market cap or net worth of $368.14 million. The enterprise value is $322.40 million.
Important Dates
The next estimated earnings date is Thursday, October 2, 2025, before market open.
| Earnings Date | Oct 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AngioDynamics has 40.63 million shares outstanding. The number of shares has increased by 1.67% in one year.
| Current Share Class | 40.63M |
| Shares Outstanding | 40.63M |
| Shares Change (YoY) | +1.67% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 3.89% |
| Owned by Institutions (%) | 71.85% |
| Float | 30.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.27 |
| Forward PS | 1.19 |
| PB Ratio | 2.03 |
| P/TBV Ratio | 3.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.21 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 10.46 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -17.50% and return on invested capital (ROIC) is -7.43%.
| Return on Equity (ROE) | -17.50% |
| Return on Assets (ROA) | -5.03% |
| Return on Invested Capital (ROIC) | -7.43% |
| Return on Capital Employed (ROCE) | -11.80% |
| Revenue Per Employee | $433,330 |
| Profits Per Employee | -$50,360 |
| Employee Count | 675 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 2.20 |
Taxes
| Income Tax | -39,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.77% in the last 52 weeks. The beta is 0.67, so AngioDynamics's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +21.77% |
| 50-Day Moving Average | 9.58 |
| 200-Day Moving Average | 9.38 |
| Relative Strength Index (RSI) | 51.69 |
| Average Volume (20 Days) | 550,382 |
Short Selling Information
The latest short interest is 3.67 million, so 9.04% of the outstanding shares have been sold short.
| Short Interest | 3.67M |
| Short Previous Month | 3.02M |
| Short % of Shares Out | 9.04% |
| Short % of Float | 12.03% |
| Short Ratio (days to cover) | 4.63 |
Income Statement
In the last 12 months, AngioDynamics had revenue of $292.50 million and -$33.99 million in losses. Loss per share was -$0.83.
| Revenue | 292.50M |
| Gross Profit | 157.71M |
| Operating Income | -24.06M |
| Pretax Income | -191.64M |
| Net Income | -33.99M |
| EBITDA | -1.66M |
| EBIT | -24.06M |
| Loss Per Share | -$0.83 |
Full Income StatementBalance Sheet
The company has $55.89 million in cash and $10.15 million in debt, giving a net cash position of $45.75 million or $1.13 per share.
| Cash & Cash Equivalents | 55.89M |
| Total Debt | 10.15M |
| Net Cash | 45.75M |
| Net Cash Per Share | $1.13 |
| Equity (Book Value) | 182.97M |
| Book Value Per Share | 4.46 |
| Working Capital | 92.13M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.13 million and capital expenditures -$10.18 million, giving a free cash flow of -$20.31 million.
| Operating Cash Flow | -10.13M |
| Capital Expenditures | -10.18M |
| Free Cash Flow | -20.31M |
| FCF Per Share | -$0.50 |
Full Cash Flow StatementMargins
Gross margin is 53.92%, with operating and profit margins of -8.23% and -11.62%.
| Gross Margin | 53.92% |
| Operating Margin | -8.23% |
| Pretax Margin | -11.63% |
| Profit Margin | -11.62% |
| EBITDA Margin | -0.57% |
| EBIT Margin | -8.23% |
| FCF Margin | n/a |
Dividends & Yields
AngioDynamics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.67% |
| Shareholder Yield | -1.67% |
| Earnings Yield | -9.23% |
| FCF Yield | -5.52% |
Analyst Forecast
The average price target for AngioDynamics is $19.00, which is 109.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.00 |
| Price Target Difference | 109.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 7.92% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AngioDynamics has an Altman Z-Score of 1.09 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.09 |
| Piotroski F-Score | 4 |